# Sarah Luppino

> Sarah Luppino is a Series A investor at M Ventures (Amsterdam) backing Medical and Life Science. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [M Ventures](https://shizune.co/investors/profile/merckventures)
- Location: Amsterdam, The Netherlands
- Total investments: 1
- Last investment: Mar 2022
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/sluppino

Sarah Luppino is a Series A investor at M Ventures in Amsterdam focused on Medical and Life Science. Sarah joined M Ventures in January 2021 as an Associate on the Technology team, focusing on investments for Frontier Tech & Sustainability and Performance Materials. Previously, she was a business strategy consultant with Mars & Co., a global boutique consulting firm. She has also worked with startups in the nanotechnology and energy &sustainability sectors. She earned her Ph.D. from MIT in organic chemistry, where her dissertation focused on the synthesis and applications of new semiconductor materials. Sarah is based in Amsterdam.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Life Science | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Concerto Biosciences | Concerto Biosciences discovers and develops specific combinations of microbial ensembles. Using kChip, a patented, high-throughput platform that constructs and screens millions of defined microbial communities - Concerto creates massive data sets on how microbes function when growing in complex communities. From these data, Concerto directlydiscovers microbial ensembles that perform a desired task and learns design rules for ensemble engineering. | $24.5M | Series A | Mar 22, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [Excelestar Ventures](https://shizune.co/investors/profile/excelestar-ventures) — VC Fund, 1 deal together
- [Horizons Ventures](https://shizune.co/investors/profile/horizons-ventures) — VC Fund, 1 deal together
- [MassVentures](https://shizune.co/investors/profile/massventures) — VC Fund, 1 deal together
- [Safar Partners](https://shizune.co/investors/profile/safar-partners-7ab4) — VC Fund, 1 deal together

## About M Ventures

VC Fund · Amsterdam, The Netherlands

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

5 contacts available at M Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Christian Patze | Associate, Performance Materials | https://shizune.co/investors/profile/christian-patze |
| Noga Yerushalmi | Head of Israel Bio-incubator | https://shizune.co/investors/profile/noga-yerushalmi |
| Sarah Luppino | Associate | https://shizune.co/investors/profile/sarah-luppino |
| Alexander Hoffmann | Principal | https://shizune.co/investors/profile/alexander-hoffmann |
| Alicia Iruzun Lafitte | Principal | https://shizune.co/investors/profile/alicia-iruzun-lafitte |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Sarah Luppino invest in?

Sarah Luppino invests primarily in Medical, Life Science and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Sarah Luppino last invest?

The most recent investment recorded for Sarah Luppino closed in Mar 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co